{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:50:11Z","timestamp":1790225411973,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["(81873112)"],"award-info":[{"award-number":["(81873112)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Project of Natural Fund of Hebei province","award":["(H2017423011)"],"award-info":[{"award-number":["(H2017423011)"]}]},{"name":"Talent Project Training Funding Project of Hebei Province","award":["(A201902015)"],"award-info":[{"award-number":["(A201902015)"]}]},{"name":"Hundred Outstanding Innovative Talents Support Program of Universities in Hebei Province","award":["(SLRC2019043)"],"award-info":[{"award-number":["(SLRC2019043)"]}]},{"name":"the Research Fund from Hebei Key Laboratory of Integrative Medicine on Liver\u2011kidney patterns","award":["(A201904)"],"award-info":[{"award-number":["(A201904)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11010-020-03861-0","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T23:08:15Z","timestamp":1596668895000},"page":"79-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1"],"prefix":"10.1007","volume":"475","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7008-8824","authenticated-orcid":false,"given":"Shenghao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhuo","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"3861_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"3861_CR2","first-page":"2141","volume":"60","author":"G Falkson","year":"1987","unstructured":"Falkson G, Ryan LM, Johnson LA, Simson IW, Coetzer BJ, Carbone PP, Creech RH, Schutt AJ (1987) A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study. Cancer 60:2141\u20132145","journal-title":"An ECOG study. Cancer"},{"key":"3861_CR3","doi-asserted-by":"crossref","unstructured":"Holditch SJ, Brown CN, Lombardi AM, Nguyen KN and Edelstein CL (2019) Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury. Int J Mol Sci 20","DOI":"10.3390\/ijms20123011"},{"key":"3861_CR4","doi-asserted-by":"crossref","first-page":"017","DOI":"10.1038\/s41467-017-01883-9","volume":"8","author":"H Sato","year":"2017","unstructured":"Sato H, Niimi A, Yasuhara T, Permata TBM, Hagiwara Y, Isono M, Nuryadi E, Sekine R, Oike T, Kakoti S, Yoshimoto Y, Held KD, Suzuki Y, Kono K, Miyagawa K, Nakano T, Shibata A (2017) DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells. Nat Commun 8:017\u201301883","journal-title":"Nat Commun"},{"key":"3861_CR5","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1158\/1078-0432.CCR-17-0950","volume":"23","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan M, Xing D, Luan L, Xu H, Sharma RB, Popovic A, Pawlik TM, Kim AK, Zhu Q, Jaffee EM, Taube JM, Anders RA (2017) Characterization of the immune microenvironment in hepatocellular carcinoma. Clin Cancer Res 23:7333\u20137339","journal-title":"Clin Cancer Res"},{"key":"3861_CR6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, Lu S, Kemberling H, Wilt C, Luber BS, Wong F, Azad NS, Rucki AA, Laheru D, Donehower R, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Greten TF, Duffy AG, Ciombor KK, Eyring AD, Lam BH, Joe A, Kang SP, Holdhoff M, Danilova L, Cope L, Meyer C, Zhou S, Goldberg RM, Armstrong DK, Bever KM, Fader AN, Taube J, Housseau F, Spetzler D, Xiao N, Pardoll DM, Papadopoulos N, Kinzler KW, Eshleman JR, Vogelstein B, Anders RA, Diaz LA Jr (2017) Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357:409\u2013413","journal-title":"Science"},{"key":"3861_CR7","doi-asserted-by":"crossref","unstructured":"Asaoka Y, Ijichi H, Koike K (2015) PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med 373(20):1979","DOI":"10.1056\/NEJMc1510353"},{"key":"3861_CR8","doi-asserted-by":"crossref","first-page":"016","DOI":"10.1186\/s40425-016-0163-8","volume":"4","author":"L Van Der Kraak","year":"2016","unstructured":"Van Der Kraak L, Goel G, Ramanan K, Kaltenmeier C, Zhang L, Normolle DP, Freeman GJ, Tang D, Nason KS, Davison JM, Luketich JD, Dhupar R, Lotze MT (2016) 5-Fluorouracil upregulates cell surface B7\u2013H1 (PD-L1) expression in gastrointestinal cancers. J Immunother Cancer 4:016\u20130163","journal-title":"J Immunother Cancer"},{"key":"3861_CR9","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1158\/0008-5472.CAN-14-3098","volume":"75","author":"J Peng","year":"2015","unstructured":"Peng J, Hamanishi J, Matsumura N, Abiko K, Murat K, Baba T, Yamaguchi K, Horikawa N, Hosoe Y, Murphy SK, Konishi I, Mandai M (2015) Chemotherapy induces programmed cell death-ligand 1 overexpression via the nuclear factor-kappab to foster an immunosuppressive tumor microenvironment in ovarian cancer. Cancer Res 75:5034\u20135045","journal-title":"Cancer Res"},{"key":"3861_CR10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tcb.2015.05.002","volume":"25","author":"CG Hansen","year":"2015","unstructured":"Hansen CG, Moroishi T, Guan KL (2015) YAP and TAZ: a nexus for Hippo signaling and beyond. Trends Cell Biol 25:499\u2013513","journal-title":"Trends Cell Biol"},{"key":"3861_CR11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato F, Cordenonsi M, Piccolo S (2016) YAP\/TAZ at the Roots of Cancer. Cancer Cell 29:783\u2013803","journal-title":"Cancer Cell"},{"key":"3861_CR12","doi-asserted-by":"crossref","unstructured":"Young K, Tweedie E, Conley B, Ames J, FitzSimons M, Brooks P, Liaw L and Vary CP (2015) BMP9 crosstalk with the hippo pathway regulates endothelial cell matricellular and chemokine responses. PLoS One 10.","DOI":"10.1371\/journal.pone.0122892"},{"key":"3861_CR13","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jhep.2014.06.033","volume":"61","author":"A Perra","year":"2014","unstructured":"Perra A, Kowalik MA, Ghiso E, Ledda-Columbano GM, Di Tommaso L, Angioni MM, Raschioni C, Testore E, Roncalli M, Giordano S, Columbano A (2014) YAP activation is an early event and a potential therapeutic target in liver cancer development. J Hepatol 61:1088\u20131096","journal-title":"J Hepatol"},{"key":"3861_CR14","first-page":"607","volume":"39","author":"YX Li","year":"2017","unstructured":"Li YX, Li JH, Zhou DW (2017) Hippo signaling pathway in liver tissue homeostasis. Yi Chuan 39:607\u2013616","journal-title":"Yi Chuan"},{"key":"3861_CR15","first-page":"35083631","volume":"412","author":"EM El-Omar","year":"2001","unstructured":"El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS (2001) The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 412:35083631","journal-title":"Nature"},{"key":"3861_CR16","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/ncb3031","volume":"16","author":"H Lanaya","year":"2014","unstructured":"Lanaya H, Natarajan A, Komposch K, Li L, Amberg N, Chen L, Wculek SK, Hammer M, Zenz R, Peck-Radosavljevic M, Sieghart W, Trauner M, Wang H, Sibilia M (2014) EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation. Nat Cell Biol 16:972\u2013977","journal-title":"Nat Cell Biol"},{"key":"3861_CR17","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1002\/cam4.2318","volume":"8","author":"Y Wu","year":"2019","unstructured":"Wu Y, Shen L, Liang X, Li S, Ma L, Zheng L, Li T, Yu H, Chan H, Chen C, Yu J, Jia J (2019) Helicobacter pylori-induced YAP1 nuclear translocation promotes gastric carcinogenesis by enhancing IL-1beta expression. Cancer Med 8:3965\u20133980","journal-title":"Cancer Med"},{"key":"3861_CR18","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1136\/gutjnl-2017-314061","volume":"67","author":"W Kim","year":"2018","unstructured":"Kim W, Khan SK, Liu Y, Xu R, Park O, He Y, Cha B, Gao B, Yang Y (2018) Hepatic hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma. Gut 67:1692\u20131703","journal-title":"Gut"},{"key":"3861_CR19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/hep.28874","volume":"65","author":"J Bergmann","year":"2017","unstructured":"Bergmann J, Muller M, Baumann N, Reichert M, Heneweer C, Bolik J, Lucke K, Gruber S, Carambia A, Boretius S, Leuschner I, Becker T, Rabe B, Herkel J, Wunderlich FT, Mittrucker HW, Rose-John S, Schmidt-Arras D (2017) IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice. Hepatology 65:89\u2013103","journal-title":"Hepatology"},{"key":"3861_CR20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cell.2011.11.026","volume":"148","author":"Z Li","year":"2012","unstructured":"Li Z, Tuteja G, Schug J, Kaestner KH (2012) Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer. Cell 148:72\u201383","journal-title":"Cell"},{"key":"3861_CR21","doi-asserted-by":"crossref","unstructured":"Zhang H, Ramakrishnan SK, Triner D, Centofanti B, Maitra D, Gyorffy B, Sebolt-Leopold JS, Dame MK, Varani J, Brenner DE, Fearon ER, Omary MB and Shah YM (2015) Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1. Sci Signal 8.","DOI":"10.1126\/scisignal.aac5418"},{"key":"3861_CR22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-5347(01)65921-4","volume":"156","author":"B Sander","year":"1996","unstructured":"Sander B, Damm O, Gustafsson B, Andersson U, Hakansson L (1996) Localization of IL-1, IL-2, IL-4, IL-8 and TNF in superficial bladder tumors treated with intravesical bacillus Calmette-Guerin. J Urol 156:536\u2013541","journal-title":"J Urol"},{"key":"3861_CR23","doi-asserted-by":"crossref","unstructured":"Matsumoto R, Tsuda M, Yoshida K, Tanino M, Kimura T, Nishihara H, Abe T, Shinohara N, Nonomura K and Tanaka S (2016) Aldo-keto reductase 1C1 induced by interleukin-1beta mediates the invasive potential and drug resistance of metastatic bladder cancer cells. Sci Rep 6.","DOI":"10.1038\/srep34625"},{"key":"3861_CR24","doi-asserted-by":"crossref","unstructured":"Szeto SG, Narimatsu M, Lu M, He X, Sidiqi AM, Tolosa MF, Chan L, De Freitas K, Bialik JF, Majumder S, Boo S, Hinz B, Dan Q, Advani A, John R, Wrana JL, Kapus A and Yuen DA (2016) YAP\/TAZ Are Mechanoregulators of TGF-beta-Smad Signaling and Renal Fibrogenesis.","DOI":"10.1681\/ASN.2015050499"},{"key":"3861_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/BD-140386","volume":"35","author":"T Nazir","year":"2015","unstructured":"Nazir T, Islam A, Omer MO, Mustafa M (2015) Lymphocytopenia; induced by vinorelbine, doxorubicin and cisplatin in human cancer patients. Breast Dis 35:1\u20134","journal-title":"Breast Dis"},{"key":"3861_CR26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/2326-6066.CIR-17-0320","volume":"6","author":"MH Kim","year":"2018","unstructured":"Kim MH, Kim CG, Kim SK, Shin SJ, Choe EA, Park SH, Shin EC, Kim J (2018) YAP-induced PD-L1 expression drives immune evasion in BRAFi-resistant melanoma. Cancer Immunol Res 6:255\u2013266","journal-title":"Cancer Immunol Res"},{"key":"3861_CR27","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.cell.2015.07.061","volume":"162","author":"W Hugo","year":"2015","unstructured":"Hugo W, Shi H, Sun L, Piva M, Song C, Kong X, Moriceau G, Hong A, Dahlman KB, Johnson DB, Sosman JA, Ribas A, Lo RS (2015) Non-genomic and immune evolution of melanoma acquiring MAPKi resistance. Cell 162:1271\u20131285","journal-title":"Cell"},{"key":"3861_CR28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/15384047.2015.1108488","volume":"17","author":"L Ma","year":"2016","unstructured":"Ma L, Cui J, Xi H, Bian S, Wei B, Chen L (2016) Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells. Cancer Biol Ther 17:36\u201347","journal-title":"Cancer Biol Ther"},{"key":"3861_CR29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1158\/0008-5472.CAN-17-0836","volume":"78","author":"A Ooki","year":"2018","unstructured":"Ooki A, Pena MCDR, Marchionni L, Dinalankara W, Begum A, Hahn NM, VandenBussche CJ, Rasheed ZA, Mao S, Netto GJ, Sidransky D, Hoque MO (2018) YAP1 and COX2 coordinately regulate urothelial cancer stem-like cells. Cancer Res 78:168\u2013181","journal-title":"Cancer Res"},{"key":"3861_CR30","unstructured":"Qin X, Liu C, Zhou Y and Wang G (2010) Cisplatin induces programmed death-1-ligand 1(PD-L1) over-expression in hepatoma H22 cells via Erk \/MAPK signaling pathway. Cell Mol Biol 11:OL1366-72."},{"key":"3861_CR31","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/2326-6066.CIR-17-0235","volume":"5","author":"L Tran","year":"2017","unstructured":"Tran L, Allen CT, Xiao R, Moore E, Davis R, Park SJ, Spielbauer K, Van Waes C, Schmitt NC (2017) Cisplatin alters antitumor immunity and synergizes with PD-1\/PD-L1 inhibition in head and neck squamous cell carcinoma. Cancer Immunol Res 5:1141\u20131151","journal-title":"Cancer Immunol Res"},{"key":"3861_CR32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbrc.2017.07.007","volume":"491","author":"BS Lee","year":"2017","unstructured":"Lee BS, Park DI, Lee DH, Lee JE, Yeo MK, Park YH, Lim DS, Choi W, Yoo G, Kim HB, Kang D, Moon JY, Jung SS, Kim JO, Cho SY, Park HS, Chung C (2017) Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcinoma. Biochem Biophys Res Commun 491:493\u2013499","journal-title":"Biochem Biophys Res Commun"},{"key":"3861_CR33","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.7150\/jca.34145","volume":"10","author":"K Liu","year":"2019","unstructured":"Liu K, Du S, Gao P, Zheng J (2019) Verteporfin suppresses the proliferation, epithelial-mesenchymal transition and stemness of head and neck squamous carcinoma cells via inhibiting YAP1. J Cancer 10:4196\u20134207","journal-title":"J Cancer"},{"key":"3861_CR34","first-page":"585","volume":"16","author":"X Wang","year":"2018","unstructured":"Wang X, Wu B, Zhong Z (2018) Downregulation of YAP inhibits proliferation, invasion and increases cisplatin sensitivity in human hepatocellular carcinoma cells. Oncol Lett 16:585\u2013593","journal-title":"Oncol Lett"},{"key":"3861_CR35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molimm.2017.12.011","volume":"94","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Wang H, Mao C, Sun M, Dominah G, Chen L, Zhuang Z (2018) Fatty acid oxidation contributes to IL-1beta secretion in M2 macrophages and promotes macrophage-mediated tumor cell migration. Mol Immunol 94:27\u201335","journal-title":"Mol Immunol"},{"key":"3861_CR36","first-page":"4625","volume":"56","author":"RD Leek","year":"1996","unstructured":"Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56:4625\u20134629","journal-title":"Cancer Res"},{"key":"3861_CR37","doi-asserted-by":"crossref","first-page":"0006562","DOI":"10.1371\/journal.pone.0006562","volume":"4","author":"B Qian","year":"2009","unstructured":"Qian B, Deng Y, Im JH, Muschel RJ, Zou Y, Li J, Lang RA, Pollard JW (2009) A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS ONE 4:0006562","journal-title":"PLoS ONE"},{"key":"3861_CR38","doi-asserted-by":"crossref","first-page":"017","DOI":"10.1186\/s13024-017-0175-y","volume":"12","author":"R Natoli","year":"2017","unstructured":"Natoli R, Fernando N, Madigan M, Chu-Tan JA, Valter K, Provis J, Rutar M (2017) Microglia-derived IL-1beta promotes chemokine expression by Muller cells and RPE in focal retinal degeneration. Mol Neurodegener 12:017\u20130175","journal-title":"Mol Neurodegener"},{"key":"3861_CR39","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4161\/cbt.29922","volume":"15","author":"J Wong","year":"2014","unstructured":"Wong J, Tran LT, Magun EA, Magun BE, Wood LJ (2014) Production of IL-1beta by bone marrow-derived macrophages in response to chemotherapeutic drugs: synergistic effects of doxorubicin and vincristine. Cancer Biol Ther 15:1395\u20131403","journal-title":"Cancer Biol Ther"},{"key":"3861_CR40","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/0008-5472.CAN-07-0912","volume":"67","author":"EY Lin","year":"2007","unstructured":"Lin EY, Pollard JW (2007) Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 67:5064\u20135066","journal-title":"Cancer Res"},{"key":"3861_CR41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2006.01.007","volume":"124","author":"J Condeelis","year":"2006","unstructured":"Condeelis J, Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124:263\u2013266","journal-title":"Cell"},{"key":"3861_CR42","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1167\/iovs.07-1154","volume":"49","author":"H She","year":"2008","unstructured":"She H, Nakazawa T, Matsubara A, Connolly E, Hisatomi T, Noda K, Kim I, Gragoudas ES, Miller JW (2008) Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization. Invest Ophthalmol Vis Sci 49:5008\u20135014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3861_CR43","doi-asserted-by":"crossref","first-page":"11279","DOI":"10.18632\/oncotarget.24397","volume":"9","author":"S Sampath","year":"2018","unstructured":"Sampath S, Won H, Massarelli E, Li M, Frankel P, Vora N, Vora L, Maghami E, Kortylewski M (2018) Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients. Oncotarget 9:11279\u201311290","journal-title":"Oncotarget"},{"key":"3861_CR44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","volume":"66","author":"X Li","year":"2017","unstructured":"Li X, Yao W, Yuan Y, Chen P, Li B, Li J, Chu R, Song H, Xie D, Jiang X, Wang H (2017) Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut 66:157\u2013167","journal-title":"Gut"},{"key":"3861_CR45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1101\/gad.294348.116","volume":"31","author":"X Guo","year":"2017","unstructured":"Guo X, Zhao Y, Yan H, Yang Y, Shen S, Dai X, Ji X, Ji F, Gong XG, Li L, Bai X, Feng XH, Liang T, Ji J, Chen L, Wang H, Zhao B (2017) Single tumor-initiating cells evade immune clearance by recruiting type II macrophages. Genes Dev 31:247\u2013259","journal-title":"Genes Dev"},{"key":"3861_CR46","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/ijc.23732","volume":"123","author":"V Levina","year":"2008","unstructured":"Levina V, Su Y, Nolen B, Liu X, Gordin Y, Lee M, Lokshin A, Gorelik E (2008) Chemotherapeutic drugs and human tumor cells cytokine network. Int J Cancer 123:2031\u20132040","journal-title":"Int J Cancer"},{"key":"3861_CR47","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1167\/iovs.18-24258","volume":"59","author":"A Futakuchi","year":"2018","unstructured":"Futakuchi A, Inoue T, Wei FY, Inoue-Mochita M, Fujimoto T, Tomizawa K, Tanihara H (2018) YAP\/TAZ are essential for TGF-beta2-mediated conjunctival fibrosis. Invest Ophthalmol Vis Sci 59:3069\u20133078","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3861_CR48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.molimm.2019.01.004","volume":"107","author":"HX Yu","year":"2019","unstructured":"Yu HX, Yao Y, Bu FT, Chen Y, Wu YT, Yang Y, Chen X, Zhu Y, Wang Q, Pan XY, Meng XM, Huang C, Li J (2019) Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells. Mol Immunol 107:29\u201340","journal-title":"Mol Immunol"},{"key":"3861_CR49","doi-asserted-by":"crossref","unstructured":"Li M, Chen J, Yu X, Xu S, Li D, Zheng Q, Yin Y (2019) Myricetin Suppresses the Propagation of Hepatocellular Carcinoma via Down-Regulating Expression of YAP. Cells 8.","DOI":"10.2139\/ssrn.3343638"},{"key":"3861_CR50","doi-asserted-by":"crossref","first-page":"14174","DOI":"10.1073\/pnas.1821194116","volume":"116","author":"AL Elaimy","year":"2019","unstructured":"Elaimy AL, Amante JJ, Zhu LJ, Wang M, Walmsley CS, FitzGerald TJ, Goel HL, Mercurio AM (2019) The VEGF receptor neuropilin 2 promotes homologous recombination by stimulating YAP\/TAZ-mediated Rad51 expression. Proc Natl Acad Sci U S A 116:14174\u201314180","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3861_CR51","doi-asserted-by":"crossref","first-page":"28976","DOI":"10.18632\/oncotarget.6721","volume":"7","author":"H Cheng","year":"2016","unstructured":"Cheng H, Zhang Z, Rodriguez-Barrueco R, Borczuk A, Liu H, Yu J, Silva JM, Cheng SK, Perez-Soler R, Halmos B (2016) Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells. Oncotarget 7:28976\u201328988","journal-title":"Oncotarget"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-03861-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-020-03861-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-03861-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T23:38:31Z","timestamp":1628206711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-020-03861-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":51,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3861"],"URL":"https:\/\/doi.org\/10.1007\/s11010-020-03861-0","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]},"assertion":[{"value":"6 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}